Skandinaviska Enskilda Banken (SEB)’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-44
Closed -$1K 892
2022
Q3
$1K Sell
44
-59
-57% -$1.78K ﹤0.01% 887
2022
Q2
$3K Hold
103
﹤0.01% 1011
2022
Q1
$4K Sell
103
-19
-16% -$650 ﹤0.01% 992
2021
Q4
$4K Sell
122
-40
-25% -$1.3K ﹤0.01% 983
2021
Q3
$5K Sell
162
-84,962
-100% -$2.72M ﹤0.01% 1007
2021
Q2
$2.58M Buy
+85,124
New +$2.8M 0.02% 604

Other funds holding OGN

Skandinaviska Enskilda Banken (SEB)'s OGN Position: Q4 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 44 shares — an estimated $1K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $2.58M in Q2 2021. 823 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 44 Organon & Co shares in Q4 2022, an estimated $1K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Organon & Co position peaked at $2.58M in Q2 2021.
  • 823 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2022, filed 8 Feb 2023.